Health Condition 1: null- Essential Hypertension Health Condition 2: Z798- Other long term (current) drug therapy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All the patients of Essential hypertension taking Antihypertensive drugs since last Three months. All the patients of Essential hypertension with or without Renal dysfunction. All the patients of Essential hypertension on Antihypertensive drugs with or without Vitamin D3 add on therapy. Adult patients between 18-60 years. Patients of either sex. Patients willing to participate in study. Ready to give written informed consent.
Exclusion criteria
Exclusion criteria: Patient suffering from Gestational hypertension. Patients of hypertension on thiazide diuretics (Hypercalcemia). Patients with history of any tumours and Patients on medication which may lead to hypercalcemia. Patients suffering from hypertension with CVS, Brain disorders. Patients suffering from chronic illness. Patients suffering from genetic disorders, hyperparathyroidism, taking antieplieptics . Patients on chronic medications other than antihypertensive.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in systolic and diastolic Blood pressure, Mean BP and Pulse pressureTimepoint: Every 15 days from the date of baseline visit to procure 6 readings of Blood pressure at an interval of 15days (Total Follow-up 6 after the first visit ) every 15 Days followup. Total time 3 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| Renal Function test Serum Vitamin D3 levels Adverse effects Timepoint: RFT and serum Vitamin D3 levels at baseline visit and at the last visit at 90 days Adverse effects monitoring at every 15 days | — |
Countries
India
Contacts
Pravara Institute of Medical Sciences